Chrysos Corp (C79)
Hi Market matters Team, Could you update your view of Chrysos Corp. (C79) after they reported on Tues - The shares dropped for a couple of days but now have picked up. Is it still on your hitlist? regards. Debbie
The Latest Q&A
Answer
Hi Debbie,
As a refresher, C79 has proprietary technology called PhotonAssay, which leverages high-energy X-rays (photons) to induce nuclear excitation in mineral samples, enabling the fast and accurate analysis of gold, silver, copper, and other elements, typically within 2 minutes.
We liked C79 FY25 result which showed strong top and bottom-line growth, driven by expanded deployments and broader partnerships. Despite a wider net loss, largely due to investment and expansion costs, the company’s prospects appear brighter, supported by robust guidance and a solid cash position.
FY25 revenue of $66.1m grew +46% YoY while they delivered earnings (Ebitda) of $16.1m relative to guidance of $9-19m range. Not a heavily covered stock by brokers with only 3 Holds & 2 Buys.
- We can see the stock trading above $7 in the coming weeks/months.
- Chrysos Corp (C79) remains in the Hitlist of our Emerging Companies Portfolio.
